844
views
0
recommends
+1 Recommend
1 collections
    1
    shares
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Mini-Review on the Safety of PTFE as a Cosmetic Ingredient

      Published
      Mini-Review
      Bookmark

            Abstract

            Per- and polyfluoroalkyl substances (PFAS) are synthetic fluorinated organic compounds known for their chemical and thermal stability, attributed to the strong carbon-fluorine bond. This bond resists biodegradation, making PFAS more likely to persist in the environment. PFAS are used as ingredients in cosmetic products due to their hydrophobicity and stability. Polytetrafluoroethylene (PTFE), commonly known as Teflon, is among the most frequently used PFAS, serving as a bulking agent and slip modifier. Despite its widespread use, PTFE, as a polymer, is not required to be registered under the European REACH regulation – limiting the availability of safety data. Studies have shown that PTFE, at concentrations relevant to cosmetic products, does not cause acute toxicity, skin irritation, or sensitization. However, subcutaneous implantation studies in animals have indicated potential for carcinogenicity. These results may not be directly relevant given the topical application of most cosmetics. There is a lack of data on the dermal absorption, distribution, metabolism, excretion, endocrine disruption, and aquatic toxicity of PTFE. The persistence and potential health risks of PFAS have led to a proposed precautionary ban in the EU even though further research is still needed to comprehensively assess the safety of PFAS, such as PTFE, in cosmetics.

            Main article text

            1 Introduction

            Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic fluorinated organic compounds that have wide industrial, professional and consumer uses. Their popularity is due to their chemical and thermal stability, a feature that is imparted by the carbon-fluorine bond, which is one of the strongest bonds in chemistry. This bond also makes PFAS highly resistant to biodegradation by most microorganisms [1]. Wastewater treatment plants (WWTPs) are therefore unable to degrade PFAS sufficiently, making them significant sources of PFAS release into the environment [2].

            Aliphatic fluorocarbons are around 1.5 times more hydrophobic than aliphatic hydrocarbons [3] and, at least in the case of interaction with protein residues, the difference is attributed to the hydrophobic surface area rather than a difference in mechanism of hydrophobicity [4]. This increased hydrophobicity combined with their outstanding stability make PFAS useful ingredients in cosmetics that are marketed as waterproof and long-lasting. In terms of the lipophilicity or lipophobicity of aliphatic fluorocarbons as compared to aliphatic hydrocarbons, the situation is more complex and may vary depending on the functional groups present [5].

            2 PTFE as a cosmetic ingredient

            Unlike Perfluorooctanoic acid (PFOA) and Perfluorooctanesulfonic acid (PFOS), which have been well studied and largely phased out due to their persistence and toxicity [6], 31 PFAS are still added as ingredients in cosmetics based on the on a survey from the US EPA that covered use during a period of one year, through March 2023 [7]. This list includes polytetrafluoroethylene (PTFE, Fig. 1), which, according to a recent study by researchers at Nantes Université in France, was the most frequently found PFAS in 765 cosmetic products studied [8]. This paper reviews current knowledge about the safety of this PFAS substance, as used in cosmetics, and addresses both the regulatory environment and the future challenges.

            Fig. 1:

            The structural formula of polytetrafluoroethylene (PTFE)

            PTFE is a fluoropolymer more commonly known as Teflon and is used in cosmetics as a bulking agent and for its friction-reducing properties [9]. It may be found in various cosmetic products including foundations, mascara and lipsticks, where it improves product texture and longevity. As a polymer, PTFE is not required to be registered under the European regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). This lack of regulatory impetus limits the amount of company-generated safety data and its public dissemination. The most comprehensive published safety assessment to date, as it relates to its use in cosmetics, is the one conducted by the US Cosmetic Ingredient Review (CIR) expert panel [9].

            3 PTFE safety studies

            In the CIR report, maximum use concentrations of 13% in leave-on products and 2.4% in rinse-off products were based on FDA’s Voluntary Cosmetic Registration Program (VCRP) database. In an acute oral toxicity study in rats, a low-molecular-weight PTFE resin did not result in any deaths or clinical effects up to 17 g/kg [9, 10]. In a 90-day study in rats fed 25% PTFE in their diet, there were no microscopic tissue changes. Nonetheless, rats fed unsintered PTFE resin had an increase in liver size [9, 10]. Nine-day inhalation studies using a 20% dispersion of low molecular weight PTFE resin in CCl2F–CClF2, in rats, showed no evidence of pathology after repeated exposure. Laboured breathing, incoordination and irritation of the nose were attributed to the propellants and the dispersing (not identified) [9, 10]. Mice exposed to an undisclosed concentration of PTFE for 6 months showed skin lesions, fur loss and a 50% weight reduction [11].

            Regarding skin irritation and sensitization, in a 48-hour semi-occlusive patch test on 26 human subjects with 7.6% PTFE as well as a 24-hour semi-occlusive patch test on 15 subjects with 12% PTFE, skin irritation was not observed [9]. A human repeated insult patch test (HRIPT) on 206 subjects with 9% PTFE showed no evidence of skin sensitization [9]. A concentration of 20% low molecular weight PTFE resin in CCl2F–CClF2 was applied to the skin of 10 guinea pigs (duration and dose per area not stated) with no evidence of skin sensitization [10]. 20% of the same substance was also applied in the eyes of an undisclosed number of New Zealand White rabbits with mild conjunctival irritation subsiding in less than 72 hours and mild corneal injury observed at 24 hours but not 48 hours. It was concluded that the reactions observed were not greater than those observed with CCl2F–CClF2 alone [10].

            In terms of genotoxicity and teratogenicity, anticohesive coating materials containing 60-73% PTFE tested negative in both the Ames test and micronucleus assay [9, 12]. A developmental toxicity study on 10 rats (5 males and 5 females) using the same materials administered once a day at doses of 1.25 g/kg and 6.25 g/kg, during gestation days 7 to 16, did not induce birth defects in rats [12].

            As for carcinogenicity, fibrosarcomas, sarcomas and fibroadenomas (some malignant) were observed in multiple subcutaneous implantation studies of PTFE disks, films, and surgical mesh, in rats and mice [1320]. These results should be taken with caution since subcutaneous implantation may not be directly relevant to the topical application of cosmetics. Moreover, it must be noted that tetrafluoroethyelene, the monomer used to make PTFE, is classified as a potential human carcinogen [21, 22], while PFOA and its substitute GenX, which may be used as processing aids in the production of PTFE [23], are on the EU Candidate List of Substances of Very High Concern for Authorisation (SHVC list) [24]. Therefore, the levels of these impurities must be kept to a minimum.

            4 Prospects

            Overall, more research would be needed on PTFE, following OECD test guidelines, and under Good Laboratory Practice (GLP), with well-defined substances in terms of molecular weight and impurity levels. Moreover, there is currently no data on dermal absorption, distribution, metabolism and excretion. Data on endocrine disruption and aquatic toxicity is also lacking. In terms of environmental fate, PTFE is neither readily biodegradable nor inherently biodegradable [25]. The concerns surrounding PFAS include their potential for endocrine disruption, reproductive toxicity, carcinogenicity, and their persistence in the environment. Additionally, there is a general lack of comprehensive high-quality data on these substances. PTFE, along with other PFAS, may therefore face a precautionary ban in the EU as part of a far-reaching PFAS restriction proposal [26]. There is a concern that such a ban would apply to certain substances simply due to a data gap rather than being a result of scientific evidence [27]. This was perhaps a problem in the making, as polymeric PFAS, such as PTFE, were never required to register under EU REACH, and a revision of the regulation to include an obligation to register certain polymers has been postponed [28].

            References

            1. Wackett LP. Why is the biodegradation of polyfluorinated compounds so rare? mSphere. 2021. Vol. 6:e0072121. [Cross Ref]

            2. Nguyen HT, McLachlan MS, Tscharke B, et al.. Background release and potential point sources of per- and polyfluoroalkyl substances to municipal wastewater treatment plants across Australia. Chemosphere. 2022. Vol. 293:133657. [Cross Ref]

            3. Kasuya MCZ, Nakano S, Katayama R, Hatanaka K. Evaluation of the hydrophobicity of perfluoroalkyl chains in amphiphilic compounds that are incorporated into cell membrane. J Fluor Chem. 2011. Vol. 132:202–206. [Cross Ref]

            4. Mecinovic´ J, Snyder PW, Mirica KA, et al.. Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the “hydrophobic wall” of carbonic anhydrase. J Am Chem Soc. 2011. Vol. 133:14017–14026. [Cross Ref]

            5. Jeffries B, Wang Z, Graton J, et al.. Reducing the lipophilicity of perfluoroalkyl groups by CF2-F/CF2-me or CF3/CH3 exchange. J Med Chem. 2018. Vol. 61:10602–10618. [Cross Ref]

            6. Wee SY, Aris AZ. Revisiting the “forever chemicals”, PFOA and PFOS exposure in drinking water. NPJ Clean Water. 2023. Vol. 6:57[Cross Ref]

            7. FDA. Per and polyfluoroalkyl substances (PFAS) in cosmetics. FDA. 2024. https://www.fda.gov/cosmetics/cosmetic-ingredients/and-polyfluoroalkyl-substances-pfas-cosmetics

            8. Céline C, Catherine B, Romane C, Laurence C. Per- and polyfluoroalkyls used as cosmetic ingredients – Qualitative study of 765 cosmetic products. Food Chem Toxicol. 2024. Vol. 187:114625. [Cross Ref]

            9. Johnson W Jr, Bergfeld WF, Belsito DV, et al.. Safety assessment of polyfluorinated polymers as used in cosmetics. Int J Toxicol. 2023. Vol. 42:144S–161S. [Cross Ref]

            10. Clayton JW Jr. Fluorocarbon toxicity and biological action. Fluor Chem Rev. 1967. Vol. 1(2):97–252

            11. Hagemeyer D, Stubblebine W. Physiological activity of fluorocarbon polymers. Mod Plast. 1954. Vol. 31:136–141

            12. Yang W. The study of the toxicity of an anticohesive coating material polytetrafluoroethylene. J China Med Univ. 1987. Vol. 16:289–293

            13. Tomatis L, Shubik P. Influence of Urethane on Subcutaneous Carcinogenesis by ‘Teflon’ Implants. Nature. 1963. Vol. 198:600–601. [Cross Ref]

            14. Tomatis L. Studies in subcutaneous carcinogenesis with implants of glass and Teflon in mice. Acta-Unio Int Contra Cancrum. 1963. Vol. 19:607–611

            15. Tomatis L. Subcutaneous carcinogenesis by implants and by 7,12-dimethylbenz[a]anthracene. Tumori. 1966. Vol. 52:1–16. [Cross Ref]

            16. Ménard S, Porta GD. Incidence, growth and antigenicity of fibrosarcomas induced by Teflon disc in mice. Tumori. 1976. Vol. 62:565–573. [Cross Ref]

            17. Oppenheimer BS, Oppenheimer ET, Stout AP, Danishefsky I. Malignant tumors resulting from embedding plastics in rodents. Science. 1953. Vol. 118:305–306. [Cross Ref]

            18. Russell FE, Simmers MH, Hirst AE, Pudenz RH. Tumors associated with embedded polymers. J Natl Cancer Inst. 1959. Vol. 23:305–315

            19. Sellers EA, Schänbaum E. Further studies on the goitrogenic action of thyroxine administered with propylthiouracil, methimazole or perchlorate. Acta Endocrinol. 1965. Vol. 49:319–330. [Cross Ref]

            20. Bryson G, Bischoff F. The limitations of safety testing. Prog Exp Tumor Res. 1969. Vol. 11:100–133. [Cross Ref]

            21. Consonni D, Straif K, Symons JM, et al.. Cancer risk among tetrafluoroethylene synthesis and polymerization workers. Am J Epidemiol. 2013. Vol. 178:350–358. [Cross Ref]

            22. ECHA. Tetrafluoroethylene Registration Dossier. https://echa.europa.eu/nl/registration-dossier/-/registered-dossier/15453/2/1

            23. Sajid M, Ilyas M. PTFE-coated non-stick cookware and toxicity concerns: A perspective. Environ Sci Pollut Res Int. 2017. Vol. 24:23436–23440. [Cross Ref]

            24. ECHA. Candidate List of substances of very high concern for Authorisation. https://echa.europa.eu/candidate-list-table?p_p_id=disslists_WAR_disslistsportlet&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_disslists_WAR_disslistsportlet_javax.portlet.action=searchDissLists

            25. Henry DB. Summary of the PTFE studies performed with independent laboratories to investigate persistence, degradation, transformation to or release of substances of concern. 2022.

            26. Tyrrell ND. A Proposal that would ban manufacture, supply, and use of all fluoropolymers and most fluorinated reagents within the entire EU. Org Process Res Dev. 2023. Vol. 27:1422–1426. [Cross Ref]

            27. Wollin K-M, Batke M, Damm G, et al.. PFASs–restriction proposal commentary on ECHA’s Annex XV restriction report, proposal for a restriction. Arch Toxicol. 2023. Vol. 97:3305–3312. [Cross Ref]

            28. European Commission. Chemicals: Commission seeks views on revision of REACH, the EU’s chemicals legislation. 2013. https://environment.ec.europa.eu/news/chemicals-commission-seeks-views-revision-reach-eus-chemicals-legislation-2022-01-20_en

            Author and article information

            Journal
            jnst
            Journal of the Netherlands Society of Toxicology
            Nederlandse Vereniging voor Toxicologie (NVT) (Bilthoven; Netherlands )
            2950-2551
            18 October 2024
            : 1
            : 2
            : 1-3
            Affiliations
            [1 ]Colonial Chemical EU B.V., Johan Cruijff Boulevard 65, 1101 DL Amsterdam, The Netherlands
            Author notes
            Correspondence: Barae Jomaa, Colonial Chemical EU B.V., Johan Cruijff Boulevard 65, 1101 DL Amsterdam, The Netherlands. E-mail: barae.jomaa@ 123456colonialchem.com
            Author information
            https://orcid.org/0009-0003-0521-7532
            Article
            10.61833/JNST.2024.0003
            bcdeb159-17d1-46af-9726-5db6b7d953ee
            2024 The Author(s).

            This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited.

            History
            : 10 October 2024
            : 11 October 2024
            : 11 October 2024
            Page count
            Figures: 1, References: 28, Pages: 3
            Categories

            PFAS (Per- and polyfluoroalkyl substances),Cosmetic regulation,Cosmetic safety,PTFE (Polytetrafluoroethylene),Carcinogenicity,Environmental persistence

            Comments

            2024-12-13 16:09 UTC
            +1

            Comment on this article